Mind Medicine Australia’s Chairman, Peter Hunt AM says:“......

  1. 899 Posts.
    lightbulb Created with Sketch. 378

    Mind Medicine Australia’s Chairman, Peter Hunt AM says:“... MDMA-assisted psychotherapy is showing very high remission rates in overseas trials and has also been shown to have high levels of safety and to be non-addictive when used in medically controlled environments. Negative side effects have also been minimal. Therapists have been specifically trained for this work through our certificate course and appropriate protocols developed with Emyria. The trial approach being taken by Emyria is also consistent with the Federal Government’s recently announced grant of $15 million for trials utilising hallucinogens or stimulant drugs supported by psychotherapy for treatment resistant mental illnesses.”

    We are partners with Mind Medicine Australia and co developed the protocols.
    She may have not herd of Emyria but I feel we will be an essential part of MDMA assisted therapy in Australia ongoing.
    2 years of background work has given us a massive head start on any others trying to get into the space.

    Also with there is a compound in the MDMA like family that has a shorter half life or "active period" I believe we will have protection on that and could become the standard.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
4.1¢
Change
0.002(5.13%)
Mkt cap ! $25.06M
Open High Low Value Volume
3.8¢ 4.1¢ 3.8¢ $61.46K 1.550M

Buyers (Bids)

No. Vol. Price($)
1 1 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 90000 3
View Market Depth
Last trade - 15.50pm 25/07/2025 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.